anti obesity
Scope
Date
~
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Regulations
Korea’s antitrust body grants conditional OK to Broadcom-VMware deal
South Korea’s antitrust regulator on Monday granted conditional approval for US smartphone components maker Broadcom Inc.’s proposed pur...
Oct 23, 2023 (Gmt+09:00)
-
The KED View
Five most common frustrations of Korean entrepreneurs
A South Korean company recently gave up on its plan to venture into the burgeoning robot market.Fair-trade regulations that prohibit the creation of...
Oct 12, 2023 (Gmt+09:00)
-
Steel
Japanese steelmakers flood South Korea on back of weaker yen
Japanese steelmakers are expanding their market shares in South Korea, backed by the yen's drop against the Korean won to the lowest in eight years....
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Science joins race to develop Wegovy competitor
Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...
Sep 13, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
S.Korean food company hy boosts cosmetics unit
South Korea’s hy, formerly Korea Yakult, has launched cosmetics made with fermented products using its self-developed lactic acid bacteria, ex...
Sep 07, 2023 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 participates in drone road show in Riyadh
South Korean leading defense company LIG Nex1 Co. took part in a drone-focused workshop "2023 Korea-Saudi Arabia Drone Road Show" in Riyadh, Saudi A...
Aug 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug
South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...
Aug 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung Pharma's sales surpass $311 mn in H1 2023
South Korea’s Boryung Corp. has alleviated the fear of falling behind in its sector expressed by its third-generation chairman Jay Kim Jung-Gy...
Jul 28, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai Wia completes flying drone interception test
Hyundai Wia Corp., an auto parts and defense unit of Hyundai Motor Group, announced on Thursday that the first shooting trial of its anti-drone syst...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
SCM Lifescience kicks off anti-hair loss product exports to SE Asia
South Korea’s stem cell tech company SCM Lifescience on Wednesday said it has started full-scale exports to Southeast Asia of its hair loss ca...
Jul 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daehwa Pharm applies for approval of anti-dementia patch in China
South Korea's Daehwa Pharm Co. is speeding up its advance into the Chinese market for anti-dementia medicine, applying for sales approval of its pat...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Aerospace invests in Israeli startup with anti-jamming tech
South Korea's Hanwha Aerospace Co. has invested in an Israeli start-up possessing anti-jamming technology to prevent interference in global position...
Apr 25, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea wary of tougher US anti-China moves for chipmakers
South Korean President Yoon Suk Yeol on Monday kicked off a six-day state visit to the US with a tough assignment: finding diplomatic solutions for ...
Apr 24, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Ransomware attacks targeting S.Korean companies on sharp rise
Global hacker groups' ransomware attacks against domestic companies and organizations in the first quarter of this year have been revealed to total ...
Apr 21, 2023 (Gmt+09:00)
-
Energy
Korea’s small nuclear reactor technology falls behind global peers
South Korea’s small-sized nuclear reactor technology has fallen behind other major countries due to the years of the previous government&rsquo...
Mar 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon Pharma to merge with anti-cancer drug developer Platbio
Kolon Pharma, the pharmaceutical affiliate of South Korea's Kolon Group, is merging with anti-cancer drug developer Platbio to advance the developme...
Mar 30, 2023 (Gmt+09:00)
-
Chemical Industry
Noroo Paint, GS E&C jointly develop anti-carbonation paint for concrete
Noroo Paint, in collaboration with GS Engineering & Construction Co., announced on Tuesday the development of "Qfit Protect," a high-performance...
Mar 14, 2023 (Gmt+09:00)
-
ESG
SKC earns ISO 37001 certification for anti-corruption management
SKC, the chemical materials unit of South Korea's second-largest conglomerate, announced on Thursday that it has received the ISO 37001 certificatio...
Mar 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma, Sanofi to jointly market Plavix
GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...
Feb 13, 2023 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1 to work with Romanian state-run defense supplier
South Korea's defense contractor LIG Nex1 Co. will join hands with ROMARM, a Romanian state-run defense company, to develop anti-aircraft missiles a...
Feb 09, 2023 (Gmt+09:00)
-
IPOs
S.Korea's InnoGene sets its public offering price at 3,000 won
InnoGene, which is seeking to be listed on the Kosdaq market at the end of this month, said on Wednesday that it has confirmed its offering price at...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea's top sci-tech school creates cutting-edge anti-drone technology
A research team at South Korea's top science and technology university has developed an anti-drone technology that can remotely neutralize a city-in...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand